Search Results1-6 of  6

  • SUGITA Toshiki ID: 9000001424757

    Articles in CiNii:1

    • Development of cell delivery system for optimal cancer immunotherapy (2005)
  • SUGITA Toshiki ID: 9000005125985

    Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation (NiBio) (2011 from CiNii)

    Articles in CiNii:12

    • Preferential Activity of Wild-type and Mutant Tumor Necrosis Factor-α against Tumor-derived Endothelial-like Cells (2000)
    • Effective Cancer Targeting Using an Anti-tumor Tissue Vascular Endotheliumm specific Monoclonal Antibody (TES-23) (2000)
    • In vivo Anti-tumor Efficacy of Polyethylene Glycol-modified Tumor Necrosis Factor-α against Tumor Necrosis Factor-resistant Tumors (1996)
  • Sugita Toshiki ID: 9000021934579

    Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation|Graduate School of Pharmaceutical Sciences, Osaka University (2009 from CiNii)

    Articles in CiNii:1

    • Arsenic Trioxide Inhibits Human T Cell-Lymphotropic Virus-1-Induced Syncytiums by Down-Regulating gp46 (2009)
  • Sugita Toshiki ID: 9000391970993

    Dept. Biopharm., Grad. Sch. Pharm. Sci., Osaka Univ.|NiBio (2007 from CiNii)

    Articles in CiNii:1

    • Development of rapid isolation of antibody specific for disease-related proteins toward proteomics drug discovery (2007)
  • Sugita Toshiki ID: 9000391971550

    Graduate School of Pharmaceutical Sciences, Osaka University|National Institute of Biomedical Innovation (NiBio) (2006 from CiNii)

    Articles in CiNii:1

    • The establishment of rapid isolation methods of antibody to disease related proteins using phage antibody library (2006)
  • Sugita Toshiki ID: 9000391997914

    National Institute of Biomedical Innovation|Graduate School of Pharmaceutical Sciences, Osaka University (2008 from CiNii)

    Articles in CiNii:1

    • Analysis of biological behavior and acute toxicity of silica nanoparticles (2008)
Page Top